Increased spontaneous activity of a network of hippocampal neurons in culture caused by suppression of inhibitory potentials mediated by anti-gad antibodies
- 1 January 2008
- journal article
- Published by Taylor & Francis in Autoimmunity
- Vol. 41 (1) , 66-73
- https://doi.org/10.1080/08916930701619565
Abstract
Anti-glutamic acid decarboxylase autoantibodies (GAD-Ab) are commonly considered the marker of autoimmune diabetes; they were first described in patients affected by stiff-person syndrome and recently, in ataxic or epileptic patients. The pathogenetic role of GAD-Ab remains unclear but inhibition of GABA synthesis or interference with GABA exocytosis are hypothesized. The aim of the study was to assess whether GAD-Ab interfere with neuronal transmission. Serum from a GAD-Ab positive epileptic patient (by IHC and RIA), serum from a GAD-positive (only by RIA) diabetic case, sera from two epileptic GAD-Ab negative patients and a normal control were selected. Post-synaptic inhibitory potentials (IPSPs) were registered on hippocampal neurons in culture before and after the application of diluted sera in a patch clamp study. A significant increase in the frequency of IPSPs was observed after application of GAD-positive epileptic serum, while no effect was noted using sera from negative controls. The inhibition in neuronal transmission only after application of GAD-positive epileptic serum, suggests an interference with GABA function and consequently with neuronal inhibition supporting a pathogenetic role of GAD-Ab in the development of epilepsy.Keywords
This publication has 30 references indexed in Scilit:
- Stiff-person syndromeCurrent Treatment Options in Neurology, 2003
- Cerebellar Ataxia With Anti–Glutamic Acid Decarboxylase AntibodiesArchives of Neurology, 2001
- Anti-gabaergic neuron autoantibodies in a patient with stiff-man syndrome and ataxiaJournal of the Neurological Sciences, 1996
- Glutamic Acid Decarboxylase – Gene to Antigen to DiseaseJournal of Internal Medicine, 1996
- Autoantibodies to Glutamate Decarboxylase in a Patient With Cerebellar Cortical Atrophy, Peripheral Neuropathy, and Slow Eye MovementsArchives of Neurology, 1995
- Autoantibodies to glutamic acid decarboxylase in palatal myoclonus and epilepsyAnnals of Neurology, 1994
- Autoantibodies Against Gad65Rather Than Gad67Precede the Onset of Type 1 DiabetesAutoimmunity, 1994
- Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type.Journal of Clinical Investigation, 1993
- Glutamic acid decarboxylase autoantibodies in preclinical insulin-dependent diabetes.Proceedings of the National Academy of Sciences, 1992
- Autoantibodies to Glutamic Acid Decarboxylase in a Patient with Stiff-Man Syndrome, Epilepsy, and Type I Diabetes MellitusNew England Journal of Medicine, 1988